Skip to content

Effect of different ultrasound-guided nerve block protocols on analgesia in shoulder arthroscopic surgery

Effect of different ultrasound-guided nerve block protocols on analgesia in shoulder arthroscopic surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500111046
Enrollment
Unknown
Registered
2025-10-24
Start date
2025-11-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Shoulder Joint Disorders

Interventions

Ultrasound-guided combined suprascapular and axillary nerve block group:Ultrasound-guided combined suprascapular and axillary nerve block with injection of 10 ml of 0.375% ropivacaine to each nerve
Ultrasound-guided combined suprascapular nerve block and coracobrachialis-subscapularis plane block group:Ultrasound-guided combined suprascapular and coracobrachialis-subscapular plane block with in

Sponsors

Yan'An hospital of Kunming City
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1.Patients undergoing unilateral shoulder arthroscopy; 2.Age between 18 and 65 years (inclusive); 3.American Society of Anesthesiologists (ASA) physical status classification I to III.; 4.The patient or the patient's legal representative is capable and willing to provide written informed consent;

Exclusion criteria

Exclusion criteria: 1. Previous obstructive or restrictive lung disease; 2.Patients with pre-existing neurological deficits or pathologies affecting nerve block, Phrenic nerve abnormality or diaphragmatic dysfunction, or those who refuse regional anesthesia; 3.Patients with severe cardiac, hepatic, or renal disease, or coagulopathy; 4.Patients with known allergy to local anesthetics, or infection, skin breakdown, or ulceration at the proposed puncture site(s); 5.Patients with psychiatric disorders precluding cooperation with the study procedures or follow-up; 6.Patients with opioid dependence; 7.Patients who decline patient-controlled analgesia (PCA); 8.Pregnant or lactating women; 9.Patients who refuse to participate in this study.

Design outcomes

Primary

MeasureTime frame
analgesic duration time;Diaphragmatic Excursion (DE);

Secondary

MeasureTime frame
The number of effective compressions, total compressions and postoperative rescue analgesia of PCIA within 48 hours after surgery;Postoperative NRS pain score;The incidence of postoperative nausea and vomiting (PONV) at 24 hours after surgery;Postoperative 24-hour QoR-15 score;total intraoperative opioid consumption;Postoperative analgesic satisfaction;

Countries

China

Contacts

Public ContactMa Longxiang

Yan'An hospital of Kunming City

630629024@qq.com+86 871 6587 8832

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026